|
Volumn 10, Issue 6, 2004, Pages 743-
|
Anticoagulation in haemophilia patients with prosthetic valve replacement [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
BLOOD CLOTTING FACTOR 8;
BLOOD CLOTTING FACTOR 8 INHIBITOR;
D DIMER;
FIBRIN;
WARFARIN;
XIMELAGATRAN;
CASE REPORT;
HEART VALVE BIOPROSTHESIS;
HEART VALVE PROSTHESIS;
HEMOPHILIA A;
HUMAN;
INTERNATIONAL NORMALIZED RATIO;
LETTER;
MALE;
MEDICAL DECISION MAKING;
MITRAL VALVE REPLACEMENT;
OPEN HEART SURGERY;
POSTOPERATIVE PERIOD;
POSTOPERATIVE THROMBOSIS;
PRIORITY JOURNAL;
TRANSESOPHAGEAL ECHOCARDIOGRAPHY;
TREATMENT OUTCOME;
ANTICOAGULANTS;
FIBRIN FIBRINOGEN DEGRADATION PRODUCTS;
HEART VALVE PROSTHESIS;
HEART VALVE PROSTHESIS IMPLANTATION;
HEMOPHILIA A;
HUMANS;
MITRAL VALVE;
THROMBOSIS;
WARFARIN;
|
EID: 11144343196
PISSN: 13518216
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1365-2516.2004.01029.x Document Type: Letter |
Times cited : (7)
|
References (4)
|